Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP ...Middle East

Medscape - News
The oral BTK inhibitor rilzabrutinib led to rapid and durable platelet responses, reduced bleeding, and improved fatigue in patients with previously treated immune thrombocytopenia. Medscape Medical News

Hence then, the article about rilzabrutinib shines in phase 3 trial of tough to treat itp was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Parade - before 11 hour & 21 minute